Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2026-01-07 @ 5:32 PM
Study NCT ID:
NCT04675827
Status:
TERMINATED
Last Update Posted:
2024-12-04
First Post:
2020-11-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade
Sponsor:
Jules Bordet Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-17
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-26
Completion Date Type:
ACTUAL
First Submit Date:
2020-11-25
First Submit QC Date:
None
Study First Post Date:
2020-12-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-02
Last Update Post Date:
2024-12-04
Last Update Post Date Type:
ACTUAL